Escalon Medical EBIT

The latest EBIT for ESMC is $-660M as of March 2026. That compares with $640K in the prior-year period — down 102731.3% year over year. That is below the sector sector average of $-6.4M. Investors often review this figure alongside Escalon Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, ESMC's EBIT moved from $640K to $-660M — a 102731.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Escalon Medical's operating scale or balance-sheet position.

Against its sector companies, ESMC currently prints $-660M for EBIT, while the sector average sits near $-6.4M. That is roughly 10132.1% below the sector mean. Large gaps often invite a closer look at Escalon Medical's growth, margins, and balance sheet.

A EBIT figure of $-660M for ESMC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-6.4M. Explore the charts below for those layers of context.

After noting ESMC's EBIT ($-660M), review year-over-year change from $640K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.